193 related articles for article (PubMed ID: 12821350)
1. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses.
Andersen ES; Knudsen A; Rix P; Johansen B
Gynecol Oncol; 2003 Jul; 90(1):109-12. PubMed ID: 12821350
[TBL] [Abstract][Full Text] [Related]
2. Risk of malignancy index in preoperative evaluation of pelvic masses.
Ashrafgangooei T; Rezaeezadeh M
Asian Pac J Cancer Prev; 2011; 12(7):1727-30. PubMed ID: 22126553
[TBL] [Abstract][Full Text] [Related]
3. The risk of malignancy index in discrimination of adnexal masses.
Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
[TBL] [Abstract][Full Text] [Related]
4. Comparison of risk of malignancy indices; RMI 1-4 in borderline ovarian tumor.
Yenen MC; Alanbay I; Aktürk E; Ercan CM; Coksuer H; Karaşahin E; Ozan H; Dede M
Eur J Gynaecol Oncol; 2012; 33(2):168-73. PubMed ID: 22611957
[TBL] [Abstract][Full Text] [Related]
5. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
[TBL] [Abstract][Full Text] [Related]
6. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
[TBL] [Abstract][Full Text] [Related]
7. Preoperative multimodal strategies for risk assessment of adnexal masses: analysis of 1362 cases in a gynecologic cancer center.
Radosa MP; Camara O; Vorwergk J; Diebolder H; Winzer H; Mothes A; Gajda M; Runnebaum IB
Int J Gynecol Cancer; 2011 Aug; 21(6):1056-62. PubMed ID: 21633301
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses.
Terzić M; Dotlić J; Ladjević IL; Atanacković J; Ladjević N
Vojnosanit Pregl; 2011 Jul; 68(7):589-93. PubMed ID: 21899180
[TBL] [Abstract][Full Text] [Related]
9. [Application values of four risk of malignancy indices in the preoperative evaluation of patients with adnexal masses].
Lou HY; Meng H; Zhu QL; Zhang Q; Jiang YX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Jun; 32(3):297-302. PubMed ID: 20602883
[TBL] [Abstract][Full Text] [Related]
10. Role of a risk of malignancy index in clinical approaches to adnexal masses.
Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses.
Auekitrungrueng R; Tinnangwattana D; Tantipalakorn C; Charoenratana C; Lerthiranwong T; Wanapirak C; Tongsong T
Int J Gynaecol Obstet; 2019 Sep; 146(3):364-369. PubMed ID: 31206642
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.
van den Akker PA; Aalders AL; Snijders MP; Kluivers KB; Samlal RA; Vollebergh JH; Massuger LF
Gynecol Oncol; 2010 Mar; 116(3):384-8. PubMed ID: 19959215
[TBL] [Abstract][Full Text] [Related]
13. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
[TBL] [Abstract][Full Text] [Related]
14. Risk of malignancy index for adnexal masses.
Akdeniz N; Kuyumcuoğlu U; Kale A; Erdemoğlu M; Caca F
Eur J Gynaecol Oncol; 2009; 30(2):178-80. PubMed ID: 19480249
[TBL] [Abstract][Full Text] [Related]
15. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses.
Timmerman D; Verrelst H; Bourne TH; De Moor B; Collins WP; Vergote I; Vandewalle J
Ultrasound Obstet Gynecol; 1999 Jan; 13(1):17-25. PubMed ID: 10201082
[TBL] [Abstract][Full Text] [Related]
16. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
[TBL] [Abstract][Full Text] [Related]
17. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
18. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
Dora SK; Dandapat AB; Pande B; Hota JP
J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
[TBL] [Abstract][Full Text] [Related]
19. Sonographic discrimination between benign and malignant adnexal masses in premenopause.
Radosa MP; Vorwergk J; Fitzgerald J; Kaehler C; Schneider U; Camara O; Runnebaum IB; Schleußner E
Ultraschall Med; 2014 Aug; 35(4):339-44. PubMed ID: 23775448
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the risk of malignancy index and self-constructed logistic regression models in preoperative evaluation of adnexal masses.
Yörük P; Dündar O; Yildizhan B; Tütüncü L; Pekin T
J Ultrasound Med; 2008 Oct; 27(10):1469-77. PubMed ID: 18809957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
